JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 8, 2006; DOI: 10.1124/jpet.106.108373


0022-3565/06/3193-1258-1264$20.00
JPET 319:1258-1264, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.108373v1
319/3/1258    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edgerton, D. S.
Right arrow Articles by Cherrington, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edgerton, D. S.
Right arrow Articles by Cherrington, A. D.

ENDOCRINE AND DIABETES

Inhalation of Human Insulin Is Associated with Improved Insulin Action Compared with Subcutaneous Injection and Endogenous Secretion in Dogs

Dale S. Edgerton, Kathryn M. Stettler, Doss W. Neal, Melanie Scott, Larry Bowen, Warren Wilson, Charles H. Hobbs, Chet Leach, Thomas R. Strack, and Alan D. Cherrington

Vanderbilt University Medical Center, Nashville, Tennessee (D.S.E., K.M.S., D.W.N., M.S., A.D.C.); Lovelace Respiratory Research Institute, Albuquerque, New Mexico (L.B., W.W., C.H.H.); Nektar Therapeutics, San Carlos, California (C.L.); and Pfizer Inc, New York, New York (T.R.S.)

This study compared the effects of endogenous (portal) insulin secretion versus peripheral insulin administration with subcutaneous or inhaled human insulin [INH; Exubera, insulin human (rDNA origin) inhalation powder] on glucose disposal in fasted dogs. In the control group, glucose was infused into the portal vein (Endo; n = 6). In two other groups, glucose was infused portally, whereas insulin was administered peripherally by inhalation (n = 13) or s.c. injection (n = 6) with somatostatin and basal glucagon. In the Endo group, over the first 3 h, the arterial insulin concentration was twice that of the peripheral groups, whereas hepatic sinusoidal insulin levels were half as much. Although net hepatic glucose uptake was greatest in the Endo group, the peripheral groups demonstrated larger increases in nonhepatic glucose uptake so that total glucose disposal was greater in the latter groups. Compared with s.c. insulin action, glucose excursions were smaller and shorter, and insulin action was at least twice as great after INH. Thus, at the glucose dose and insulin levels chosen, peripheral insulin delivery was associated with greater whole-body glucose disposal than endogenous (portal) insulin secretion. INH administration resulted in increased insulin sensitivity in nonhepatic but not in hepatic tissues compared with s.c. delivery.


Received for publication May 24, 2006
Accepted September 6, 2006.

Address correspondence to: Dr. Dale S. Edgerton, Molecular Physiology and Biophysics, Vanderbilt University Medical Center, 710 Robinson Research Building, Nashville, TN 37232-0615. E-mail: dale.edgerton{at}vanderbilt.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. S. Edgerton, A. D. Cherrington, D. W. Neal, M. Scott, M. Lautz, N. Brown, J. Petro, C. H. Hobbs, C. Leach, A. Del Parigi, et al.
Inhaled Insulin Is Associated with Prolonged Enhancement of Glucose Disposal in Muscle and Liver in the Canine
J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 970 - 975.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.